http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002541069-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-703 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
filingDate | 2000-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2002-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2002541069-A |
titleOfInvention | HIV peptides, antigens, vaccine compositions, immunoassay kits and methods for detecting antibodies induced by HIV |
abstract | (57) [Summary]nThe present invention provides a new and modified ability to elicit an HIV-1 specific immune response without antagonizing cytotoxic T cell activity in order to achieve an effective prophylactic and therapeutic vaccine against HIV Including peptides. The peptide is based on a conserved region of the HIV gag p24 protein. An antigen in free or carrier-bound form comprising at least one of said peptides, a vaccine composition containing at least one of the antigens, an immunoassay kit and HIV or HIV specific using such antigens Methods for detecting antibodies elicited by peptides have been described. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015520179-A |
priorityDate | 1999-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.